Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients [Phase 1]
Phase 1 trial of Cabotamig (ARB202) in advanced gastrointestinal cancers has completed; no specific efficacy results are provided in the doc…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients [Phase 1, Phase 2]
This update reports on a Phase 1/2 trial of peripheral blood lymphocytes transduced with a murine T-cell receptor recognizing the G12D varia…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Reinforced Pancreaticojejunostomy With or Without glubran2 [Phase 2]
A Phase 2 clinical trial evaluating reinforced pancreaticojejunostomy with or without Glubran2 surgical adhesive in pancreatic and periampul…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI [Phase 1]
Phase 1 clinical trial update evaluating a Technetium-99m labeled HYNIC-FAPI imaging agent to visualize fibroblast activation protein expres…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Trial Evaluating Combined Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating a combined chemotherapy regimen in metastatic pancreatic adenocarcinoma has completed enrollment.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer [Phase 2]
Phase 2 study of zolbetuximab (IMAB362) in adults with pancreatic cancer is active but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Pancreatic Cancer and Carbon Ion Radiotherapy [NA]
This clinical trial update shows that a study on pancreatic cancer using carbon ion radiotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Michigan Genetic Hereditary Testing (MiGHT) [NA]
The MiGHT hereditary genetic testing trial at the University of Michigan Rogel Cancer Center has completed, evaluating testing across multip…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) [Phase 2]
Phase 2 basket study evaluating entrectinib in solid tumors harboring NTRK1/2/3, ROS1, or ALK gene rearrangements; the study is listed as Ac…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Combining Epigenetic And Immune Therapy to Beat Cancer. [Phase 2]
A Phase 2 trial from Institut Bergonié evaluating a combination of epigenetic therapy and immunotherapy in several advanced cancers has comp…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Choices About Genetic Testing And Learning Your Risk With Smart Technology [NA]
A completed Rutgers-led trial evaluated choices about genetic testing and learning cancer risk using smart technology across multiple cancer…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Surgical Management of Pancreatic Cancer With Liver Metastasis (Oligometastasis)
Clinical trial assessing surgical management of pancreatic cancer with liver metastases (oligometastasis) has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer [Phase 2]
A Mayo Clinic–sponsored Phase 2 trial evaluating standard chemotherapy with or without stereotactic body radiation therapy for oligometastat…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide [EARLY_Phase 1]
First-in-human Phase 1 PET imaging study of the 18F-αvβ6-binding peptide, a radiotracer targeting αvβ6, is active but not currently recruiti…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts Study
This document provides an update on a completed study examining the clinical, radiologic, pathologic, and molecular marker characteristics o…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 1, Phase 2]
An ongoing Phase 1/2 trial evaluating pancrelipase in metastatic pancreatic ductal adenocarcinoma. The study is currently active but not rec…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer [Phase 1, Phase 2]
LOAd703, an oncolytic virus therapy, was studied in a Phase 1/2 trial for pancreatic cancer and the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering [Phase 1, Phase 2]
A Phase 1/2 study evaluating autologous tumor-infiltrating lymphocytes edited by CRISPR to inhibit CISH for metastatic gastrointestinal canc…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Pancreatic Adenocarcinoma Signature Stratification for Treatment [Phase 2]
Phase 2 pancreatic cancer trial focusing on signature-based stratification for treatment. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy [Phase 1]
A Phase 1, non-randomized study evaluating the safety of adding anakinra to standard chemotherapy in pancreatic cancer; the trial has comple…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Comparison of Prognosis Between Open Pancreatic Surgery With Vein Resection and Reconstruction Versus Minimally Invasive Pancreatic Surgery With Vein Resection and Reconstruction for Pancreatic Cancer
This completed clinical trial compares prognosis following open pancreatic surgery with vein resection and reconstruction to minimally invas…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma [Phase 1, Phase 2]
The Phase 1/2 trial evaluating CMP-001 and INCAGN01949 for stage IV pancreatic cancer and other non-melanoma solid tumors was terminated; re…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating IBI343 in combination with chemotherapy as neoadjuvant therapy for borderline resectable pancreatic c…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Niraparib as First Line Therapy With Metastatic Homologous Repair-deficient Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating niraparib as first-line therapy for metastatic homologous recombination-deficient pancreatic cancer has been term…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors [Phase 1]
Phase 1 study of palbociclib in combination with gedatolisib in patients with advanced solid tumors, including lung squamous cell carcinoma,…